In a round of equity financing, Osseon Therapeutics has raised $14 million. Santa Rosa, CA-based Osseon develops and commercializes medical devices used for minimally invasive treatments for degenerative bone and joint disease. The company plans to use the new capital to expand its VCF device product line and continue with its goal of providing devices for the treatment of vertebral compression fractures.
